chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe arm and leg pain on left side.; severe arm and leg pain on left side.; numbness in both arm; numbness/leg on left side; Left side of my face went numb; I also developed a large lump on the left side of my neck that lasted for 6 weeks; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Oct2021 (Batch/Lot number: unknown) at the age of 43 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU VACCINE VII taken for immunisation, administration date 17Sep2021. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 17Sep2021, when the patient was 43 years old, for Covid-19 Immunization, reaction(s): "severe arm and leg pain on left side", "severe arm and leg pain on left side". The following information was reported: PAIN IN EXTREMITY (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "recovered" (2022) and all described as "severe arm and leg pain on left side."; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovered" (2022), described as "numbness in both arm"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovered" (2022), described as "numbness/leg on left side"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovered" (2022), described as "Left side of my face went numb"; SWELLING (non-serious) with onset 2021, outcome "recovered" (2022), described as "I also developed a large lump on the left side of my neck that lasted for 6 weeks". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, pain in extremity, hypoaesthesia, hypoaesthesia, hypoaesthesia, swelling. Reported Event: After both the first and second dose severe arm and leg pain on left side.  After second shot along with the severe pain numbness in both arm and leg on left side as well as the left side of her face went numb for about 24 hours. The patient also developed a large lump on the left side of her neck that lasted for 6 weeks.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient reported injection site reaction - red, warm to the touch, hard "knot" under the skin about the "size of a 50 cent piece." Patient stated it was painless and she has been applying ice to the area.
My period is very light, barely spotting. This never happens to me and there is zero chance I am pregnant.
When I had my booster vaccine, I had a headache, metallic taste in my mouth, and about 12 hours of violent shaking chills. I did not have a fever from what I could tell but was feeling miserable. The next day in the evening I was feeling back to normal. I was exposed to someone with COVID-19 and I then tested on a Sunday and got a positive COVID-19 test on 06/05/2022. My symptoms are mainly a cough, congesting, etc. I do have similar symptoms to my usual seasonal allergies. I am still experiencing these symptoms as well and the congestion seems to have gotten a little worse. However I am not coughing anymore.
Patient states his arm hurt since he received the injection. Right upper arm red from mid forearm to upper arm to arm pit, area not tender touch. Patient states he receive inject to back of arm.
PATIENT DEVELOPED RASH ON BACK AND STOMACH AREA.  MOTHER STATES CHILD HAS BEEN FINE OTHERWISE.  HAS HAD NO FEVER NO LOSS OF APPETITE NOR SLEEP.  CHILD VERY ALERT, VERY HIMSELF.  VACCINE ADMINISTERED AT THIS TIME WERE MMR, PEDIARIX AND HEP-A. NO ILLNESS AT TIME OF VISIT.
-There was no adverse event at all. -Vaccine was administered 2 days past BUD, but several months before product expiration. -We reached out to Pfizer, the CDC, and to the patient, and offered patient a re-vaccination but he declined, stating he didn't really care about the vaccine in the first place but only needed to show proof for upcoming travels.
Presented to ER on 10/26/14 with vomiting. Also passed stool and thickened red blood from return after the stool. No fever air enema was attempted multiple times but were not able to reduce his intussusception. Patient then went to surgery.
Fever; Body aches; Nausea; Vomiting; Diarrhea; Headache; This is a spontaneous report from a contactable physician, consumer and healthcare professional. These contactable physician, consumer and healthcare professional reported similar events for two patients. This is the first of the two reports.  A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA, Lot number: AR9309; Expiration date: Feb2021), with route of administration and therapy date unspecified, at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had fever, body aches, nausea, vomiting, diarrhea and headache. The outcome of the events, fever, body aches, nausea, vomiting, diarrhea and headache, was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019303620 same reporter/drug/events, different patient
I noticed that my injection site had gotten larger, harder, sore and red.  Slight headache off and on since injection on 3/25
MD reported 4 1/2 yr old vaccinated with MMR on 17-JUL-90 developed a fever varying between 105 & 106 degrees F four to five hrs after vaccination.  Pt was hospitalized.  At time of report fever persisted.  No reaction to first MMR.
Fever that won't break for 3 days, chills, uncontrollable jerking, Horrible headache (couldn't lift head up), loss of taste (on day 2 only) (taste returned on day 3) day 3 soreness down the arm.
I had the flu was after my last shot; Initial information was received on 22-Feb-2022 regarding an unsolicited valid Social media non-serious case received from a consumer.  This case involves a patient of unknown demographics who reported that he/she got flu after receiving vaccine Influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect Influenza vaccine produced by unknown manufacturer (formulation, strength, batch number, expiration date: unknown) via unknown route in an unknown administration site for immunization.  Information on batch number was been requested.  On an unknown date, the patient reported a non-serious that he/she got flu (influenza) (unknown latency) following the administration of Influenza vaccine.  Action Taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (influenza).  At time of reporting, the outcome was Unknown for the event (influenza).
Information has been received from a registered nurse concerning a 46 year old female with a history of knee problems and an allergy to band aids, who on 02-JUL-2008 was vaccinated IM in the left deltoid with a 10mcg first dose of RECOMBIVAX HB (Lot # 660951/0398X).  Concomitant therapy included PERCOCET, LEXAPRO and ALEVE.  Subsequently, on an unspecified date, the patient experienced neck stiffness on the left side.  The patient recovered from neck stiffness on an unspecified date.  On 12-AUG-2008 the patient was vaccinated IM in the left deltoid with a second dose of RECOMBIVAX HB (Lot # 660951/0398X).  There were no illnesses at the time of the vaccination.  On 13-AUG-2008 the patient experienced stiffness and soreness of her neck and left shoulder that lasted approximately two weeks.  The second time was more pronounced than the first time.  The patient sought unspecified medical attention.  No laboratory diagnostics were performed.  The patient recovered on 27-AUG-2008.  No product quality complaint was involved.  Additional information had been requested.
Information has been received from a nurse concerning a 50 year old female who in 1995 was vaccinated with one dose of VARIVAX (Oka/Merck) (lot# not provided). Subsequently the patient had a negative titer. No adverse effects noted from the negative titer. The patient sought medical attention in the office. Additional information has been requested.
Nurse administered FLUVIRIN lot #1620001, approximately 15 minutes after vaccine administration patient stated shortness of breath, presented with edema to neck, and hyper extension of fingers. EMS activated, and patient was taken to the hospital.
This spontaneous report as received from a registered nurse refers to a 18 year old patient (unspecified gender). On 29-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route were not provided) (lot # K008931 exp. 04-MAR-2017; lot # K009482 exp. 06-MAR-2017) which was exposed to below 36F for 361.81 hours. The nurse was requesting assistant in determining revaccination. In addition, excursion below 32F (31.2F) started on 13-JUL-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This case meets criteria for vaccine breakthrough review. SxS include SOB, coughing, feeling hot and cold, trouble sleeping, nausea, lack of appetite, sore through.
Suspected vaccination failure; Now has shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's child. The age at vaccination was not reported. After receiving Shingles vaccine, the patient had shingles at the time of reporting. The reporter stated that, the vaccine was not recent either. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset and laboratory confirmation of shingles were not provided.
swelling, redness, itch, warm to touch; sx started 24 hrs p/inj; started on ATB 10cm x 15cm LAT;
moderate body aches; heaviness as if I'm getting over something; doesn't feel well; really really cold; heaviness; severe body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DISCOMFORT (heaviness), PAIN (severe body aches), NASOPHARYNGITIS (really really cold), MALAISE (doesn't feel well) and PAIN (moderate body aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced DISCOMFORT (heaviness) and PAIN (severe body aches). On 01-Apr-2021, the patient experienced NASOPHARYNGITIS (really really cold). On 06-Apr-2021, the patient experienced MALAISE (doesn't feel well). On an unknown date, the patient experienced PAIN (moderate body aches) and DISCOMFORT (heaviness as if I'm getting over something). On 31-Mar-2021, DISCOMFORT (heaviness) and PAIN (severe body aches) outcome was unknown. On 01-Apr-2021, NASOPHARYNGITIS (really really cold) outcome was unknown. At the time of the report, MALAISE (doesn't feel well), PAIN (moderate body aches) and DISCOMFORT (heaviness as if I'm getting over something) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Noticed at approx. 7pm that his right shoulder and arm were swollen, red and warm. Had pain in the shoulder joint. Right hand swollen. had some nausea. Went to ER at about 3 am and was given a pain shot and sent home a couple of hrs. later.
Patient complained of tingling sensation of the mouth and tongue, no numbness, sensation remains intact., not in respiratory distress, able to respond verbally.  Patient stated that she also experienced tingling on f the mouth and tongue and pain on lower back after her first dose, but resolved after 15 minutes.
R lateral anterior thigh site of injection noted some swelling/redness and warm/tender to touch. No ? Treated 1/8/03. Motrin 1 tsp 2-3x/day ? 40mg BID x 5 days.
Pt complained of being very thirsty, chills, headache, dizziness and 104 degree F fever that started 2-4 hours after administration and lasted about 24 hours. Did not seek medical attention. Reported no local inj. site reaction.
MINOR ACHE IN SOME PART OF THE BODY AND WHOLE BODY ACHE; FEELING OF WARMTH; CHILLS; NAUSEA; WEAKNESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 09:50 a.m. for prophylactic vaccination on left arm. No concomitant medications were reported. On 13-MAR-2021 17:00, the subject experienced minor ache in some part of the body and whole body ache. On 13-MAR-2021 17:00, the subject experienced feeling of warmth. On 13-MAR-2021 17:00, the subject experienced chills. On 13-MAR-2021 17:00, the subject experienced nausea. On 13-MAR-2021 17:00, the subject experienced weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient recovered from chills on 13-MAR-2021, was recovering from minor ache in some part of the body and whole body ache, had not recovered from nausea, and feeling of warmth, and the outcome of weakness was not reported. This report was non-serious.
Slipped down; Left broken femur above the knee; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (Slipped down) and FEMUR FRACTURE (Left broken femur above the knee) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Bone operation in April 2021.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced FALL (Slipped down) (seriousness criterion hospitalization) and FEMUR FRACTURE (Left broken femur above the knee) (seriousness criterion hospitalization). The patient was hospitalized from 01-Apr-2021 to 07-Apr-2021 due to FALL and FEMUR FRACTURE. At the time of the report, FALL (Slipped down) and FEMUR FRACTURE (Left broken femur above the knee) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was at nursing home at the time of reporting.  Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Narrative:  6 days after vaccine developed frequent diarrhea, day and night. has lasted 4 days so far but abating. Nausea without vomiting x 2 days, resolved.
I received my 3rd dose on 01/21/2022. My symptoms started on 06/07/2022 I had heart palpation; I couldn't breath; I called my doctor and they did several tests also they put a heart monitor patch told me to go to a cardiologist. I have to wait for the cardiologist to see what is going on. I have low energy. I am not like the way I used to.
Sudden onset Afib. hospitalized in ICU for observation. performed defibrillation procedure to shock heart into normal rythm.
Patient has experienced ringing in ears since getting the vaccine; not a huge deal, just annoying. Message left on 12/30/20.
About a week after the 1st Moderna vaccine, my arm had a perfectly red circle where the injection site was and was itchy. It lasted maybe a week. Ice made it feel a lot better.
Patient woke up the day after vaccination on 03/23/2021 with tingling feeling in arm. She felt as if she slept on it wrong. On Thursday, 03/25/2021, her arm was still in pain and she spoke with her doctor. The doctor believed a nerve was hit during the administration of the vaccination. She was prescribed Ultram with a plan for follow-up in 1 week.
Information has been received from a pharmacist concerning a 70 year old male patient with a history of resolved cancer who on 25-MAR-2008 was vaccinated SC with a .65 mL dose of zoster vaccine live (Oka/Merck) (lot # 658602/1080U). Concomitant therapy included LIPITOR and FLOMAX. Subsequently, on an unspecified date the patient developed large bruise in deltoid area described as 3-4 inches in diameter. The bruise was still present on 23-APR-2008 but was smaller. The bruise was observed by a pharmacy technician, not the pharmacist who administered the vaccine. Additional information has been requested.
Received vaccination in L upper arm; L breast swollen, painful, hard, and red. L arm lymph nodes swollen and hard radiating down my arm to just above elbow.
soreness/Sore at the injection site; red spot the size of a quarter at the injection site; injection site swollen; injection site itching/itching a little bit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness/Sore at the injection site), VACCINATION SITE ERYTHEMA (red spot the size of a quarter at the injection site), INJECTION SITE SWELLING (injection site swollen) and VACCINATION SITE PRURITUS (injection site itching/itching a little bit) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included OLMESARTAN, APIXABAN (ELIQUIS), HYDROCHLOROTHIAZIDE, ATORVASTATIN, METOPROLOL TARTRATE, HYDRALAZINE, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS 2), VITAMIN C [ASCORBIC ACID], BIOTIN, VITAMIN D3, CALCIUM and ELDERBERRY [SAMBUCUS NIGRA].    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness/Sore at the injection site), VACCINATION SITE ERYTHEMA (red spot the size of a quarter at the injection site), INJECTION SITE SWELLING (injection site swollen) and VACCINATION SITE PRURITUS (injection site itching/itching a little bit). At the time of the report, VACCINATION SITE PAIN (soreness/Sore at the injection site), VACCINATION SITE ERYTHEMA (red spot the size of a quarter at the injection site), INJECTION SITE SWELLING (injection site swollen) and VACCINATION SITE PRURITUS (injection site itching/itching a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment were provided
Patient reported pain and swelling in arm injection site, pain radiating to neck, and a sore throat. Symptoms started the day of the injection (9/24/18) and resolved on 9/29/18 without needing treatment.
Patient was given the Covid 19 vaccine and was being monitored following vaccination. Within 15 minutes her upper lip started to swell and redness in the face.  Blood pressure was monitored and was high ( around 230/110). Pulse ox was put on her finger. Oxygen levels were stable. Gave patient two benedryl tablets.  No throat closing or trouble breathing. Patient went with wife to ER.  From what I am told, patient given steroids in the hospital. She was released a few hours later and is at home now. Patient is currently stable at home.
This is a spontaneous report from a contactable physician via Pfizer Sales Representative. A 83-year-old female patient of an unspecified ethnicity received a single dose of PREVNAR 13, and influenza vaccine, both via an unspecified route of administration in the same arm on 22Oct2014. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2014, the patient experienced redness, soreness and swelling of deltoid. The patient was seen in urgent care. The Pfizer Sales Representative believed that patient had these adverse events on the next day of vaccination but he was not sure. It was reported that patient received unspecified antibiotic as treatment of these events. Patient still have these symptoms after nine days of the administration; the outcome of the events was not recovered. Causality was not provided. Follow-up (17Nov2014): New information reported from the same contactable physician includes: Follow-up attempts completed. No further information expected.
Information has been received from a physician concerning a male pt in his 40's with a concurrent condition of multiple sclerosis who on 06Aug04 was vaccinated at 16:30 with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included MS medications. On 07Aug04, Saturday morning, the pt reported to the physician that he had developed a fever, chills, myalgia, arthralgia, vomiting, headache, diarrhea, rash that was warm and tender to the touch, the injection site swelled to 13x10cm and was incapacitated and unable to eat until Sunday 08Aug04. It was noted that the pt was able to return to work on Monday, 09Aug04. It was also noted that there was no intervention to prevent serious criteria. Unspecified medical attention was sought. Subsequently, the pt improved after a few days and recovered on 09Aug04. The physician considered the fever, chills, myalgia, arthralgia, vomiting, headache, diarrhea, rash, warm and tender to touch, injection site swelled, unable to eat and incapacitated to be significantly disabling. Additional information has been requested.
Localized reaction at vaccination site. Dx: Post vaccination inflammation. Tx: cold/warm compress 4x a day TYLENOL 500 mg every 4 hours (MOTRIN) ibuprofen 400 mg every 6 hours for ache.
This spontaneous report was received from a physician refers to unspecified number of patients of an unknown age. The patients' concurrent conditions, medical history and concomitant medications were not reported. The physician stated that the patients were vaccinated with improperly stored VAQTA (lot # L030442, expiry date 19-DEC-2016) (34 F for 4 hours) between 24-DEC-2015 and 12-JAN-2016. No adverse events were reported. This is one of the several reports received from the same reporter. Additional information has been requested.